Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Ichi Hashimoto

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biotechnology & Genetic Engineering Reviews|December 7, 2007
Modulation of immunoglobulin gene conversion in chicken DT40 by enhancing histone acetylation, and its application to antibody engineeringHidetaka Seo, Takatomi Yamada, Shu-ichi Hashimoto, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|February 27, 2008
Modulation of immunoglobulin gene conversion frequency and distribution by the histone deacetylase HDAC2 in chicken DT40Waka Lin, Shu-Ichi Hashimoto, Hidetaka Seo, et al.
Nature Protocols|April 5, 2007
An ex vivo method for rapid generation of monoclonal antibodies (ADLib system)Hidetaka Seo, Shu-ichi Hashimoto, Kyoko Tsuchiya, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 7, 2022
Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivoMargherita Passariello, Asami Yoshioka, Kota Takahashi, et al.
Immunity|August 23, 2005
Novel role of the Ras cascade in memory B cell responseYoshimasa Takahashi, Ayako Inamine, Shu-Ichi Hashimoto, et al.
International Journal of Molecular Sciences|April 12, 2022
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor EfficacyMargherita Passariello, Asami Yoshioka, Kota Takahashi, et al.
Cell Death Discovery|February 10, 2025
Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeuticsMargherita Passariello, Lorenzo Manna, Rosa Rapuano Lembo, et al.
Vaccine|February 26, 2013
Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosisManabu Ato, Yoshimasa Takahashi, Hideki Fujii, et al.
Mabs|October 6, 2022
Fast-tracking antibody maturation using a B cell-based display systemHitomi Masuda, Atsushi Sawada, Shu-Ichi Hashimoto, et al.
Japanese Journal of Infectious Diseases|May 23, 2007
Formalin-treated UV-inactivated SARS coronavirus vaccine retains its immunogenicity and promotes Th2-type immune responsesYasuko Tsunetsugu-Yokota, Manabu Ato, Yoshimasa Takahashi, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biotechnology & Genetic Engineering Reviews|December 7, 2007
Modulation of immunoglobulin gene conversion in chicken DT40 by enhancing histone acetylation, and its application to antibody engineeringHidetaka Seo, Takatomi Yamada, Shu-ichi Hashimoto, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|February 27, 2008
Modulation of immunoglobulin gene conversion frequency and distribution by the histone deacetylase HDAC2 in chicken DT40Waka Lin, Shu-Ichi Hashimoto, Hidetaka Seo, et al.
Nature Protocols|April 5, 2007
An ex vivo method for rapid generation of monoclonal antibodies (ADLib system)Hidetaka Seo, Shu-ichi Hashimoto, Kyoko Tsuchiya, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 7, 2022
Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivoMargherita Passariello, Asami Yoshioka, Kota Takahashi, et al.
Immunity|August 23, 2005
Novel role of the Ras cascade in memory B cell responseYoshimasa Takahashi, Ayako Inamine, Shu-Ichi Hashimoto, et al.
International Journal of Molecular Sciences|April 12, 2022
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor EfficacyMargherita Passariello, Asami Yoshioka, Kota Takahashi, et al.
Cell Death Discovery|February 10, 2025
Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeuticsMargherita Passariello, Lorenzo Manna, Rosa Rapuano Lembo, et al.
Vaccine|February 26, 2013
Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosisManabu Ato, Yoshimasa Takahashi, Hideki Fujii, et al.
Mabs|October 6, 2022
Fast-tracking antibody maturation using a B cell-based display systemHitomi Masuda, Atsushi Sawada, Shu-Ichi Hashimoto, et al.
Japanese Journal of Infectious Diseases|May 23, 2007
Formalin-treated UV-inactivated SARS coronavirus vaccine retains its immunogenicity and promotes Th2-type immune responsesYasuko Tsunetsugu-Yokota, Manabu Ato, Yoshimasa Takahashi, et al.
Pageof 2